NEWS
Date
The University of Oklahoma Gallogly College of Engineering is deeply saddened to announce the passing of Dean Emeritus Thomas Landers, who served OU for 21 years, including 14 years as dean of the college, until his retirement in 2019.
Under his leadership, OU Engineering experienced a period of remarkable growth and transformation. Dean Landers oversaw the opening of the ExxonMobil Lawrence G. Rawl Engineering Practice Facility, Devon Energy Hall, and Gallogly Hall, as well as the establishment of the Stephenson School of Biomedical Engineering. These achievements helped expand opportunities for students and faculty while positioning the college for continued success.
“Dean Landers’ vision and leadership shaped the future of engineering at OU in profound ways,” said John Klier, current dean of the Gallogly College of Engineering. “Beyond the facilities and programs he helped bring to life, his greatest legacy is the community he fostered—his care for students, faculty, staff, and alumni continues to inspire us today.”
Dean Landers will be remembered not only for his accomplishments, but also for the meaningful relationships he built across the OU community.
Those wishing to honor his legacy may do so with a gift to the Tom L. Landers Memorial Scholarship, which supports future generations of OU Engineering students.
View obituary: https://www.schaudtfuneralservice.com/obituaries/thomas-landers
The University of Oklahoma Honors College hosted its 38th annual Undergraduate Research Day on April 16 in the Thurman J. White Forum Building. Over 300 people attended, and 175 students presented their posters and projects to visitors, faculty members, judges and peers.
The Collaborative Doctor of Education (Ed.D.) in Educational Leadership offers emerging leaders across Oklahoma’s PK–12 public education system a doctoral experience designed to be as relevant as it is rigorous.
A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led by Dharambir Sanghera, Ph.D., of the University of Oklahoma, represents a step toward targeting the diseases more precisely.
